{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T22:41:50Z","timestamp":1777934510752,"version":"3.51.4"},"reference-count":7,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T00:00:00Z","timestamp":1633392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Oncol Pharm Pract"],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Adermatoglyphia is defined as the medical condition clinically diagnosed to those who have a congenital or acquired loss of the epidermal ridges on the fingertips, commonly known as fingerprints. Capecitabine, a fluoropyrimidine, is the treatment of choice in a myriad of tumors and has occasionally been reported to cause adermatoglyphia as a secondary effect upon its use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case Report<\/jats:title>\n                    <jats:p>A 52-year-old female patient, diagnosed with stage IV metastatic left breast cancer with extension to bone in late 2011 reported upon biopsy a hormone receptor positive Her2 negative ductal carcinoma. After initial treatment with a combined radiotherapy and chemotherapy palliative treatment, hepatic and lung metastasis progression obliged capecitabine oral intake. In 2018, after two years on the fluoropyrimidine (capecitabine), the patient reported adermatoglyphia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Management &amp; Outcome<\/jats:title>\n                    <jats:p>The patient opted to continue taking the medication, since such treatment was working with no other meaningful side effects. Her last work-up studies continue to show complete lung and liver response with stable bone disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Capecitabine is a common drug in the therapy against metastatic breast cancer due to its manageable safety profile. Hand-foot syndrome is a frequent side effect caused by this drug, with dosage adjustment recommended with progression of symptoms. Recent publications have reported adermatoglyphia as a rare side effect of capecitabine use. Upon further examination through dermatoscopy and biopsy, the patient was evidenced to have lost the epidermal ridges that form fingerprints. A score of 9 on the Naranjo scale confirmed to be a consequence of the administration of capecitabine.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/10781552211045009","type":"journal-article","created":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T13:07:15Z","timestamp":1633439235000},"page":"495-499","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":5,"title":["Capecitabine induced fingerprint loss: Case report and review of the literature"],"prefix":"10.1177","volume":"28","author":[{"given":"Zuratzi","family":"Deneken-Hernandez","sequence":"first","affiliation":[{"name":"ABC Medical Center, Mexico, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5348-7885","authenticated-orcid":false,"given":"Marcos","family":"Cherem-Kibrit","sequence":"additional","affiliation":[{"name":"Anahuac University, Mexico, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Guti\u00e9rrez-Andrade","sequence":"additional","affiliation":[{"name":"Anahuac University, Mexico, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgina","family":"Rodr\u00edguez-Guti\u00e9rrez","sequence":"additional","affiliation":[{"name":"Medica Sur Medical Center, Mexico, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Oswaldo","family":"Colmenero-Mercado","sequence":"additional","affiliation":[{"name":"Medica Sur Medical Center, Mexico, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2021,10,5]]},"reference":[{"key":"bibr1-10781552211045009","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-011-9652-2"},{"key":"bibr2-10781552211045009","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2005.01.005"},{"key":"bibr3-10781552211045009","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2016.2638"},{"key":"bibr4-10781552211045009","doi-asserted-by":"crossref","first-page":"218","DOI":"10.4067\/S0370-41061977000400003","volume":"48","author":"Morizon LG","year":"1977","journal-title":"Revista chilena de pediatr\u00eda"},{"key":"bibr5-10781552211045009","volume":"11","author":"Sarfraz N","year":"2019","journal-title":"Cureus"},{"key":"bibr6-10781552211045009","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.11.013"},{"key":"bibr7-10781552211045009","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154"}],"container-title":["Journal of Oncology Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10781552211045009","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10781552211045009","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10781552211045009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T02:25:33Z","timestamp":1777688733000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10781552211045009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,5]]},"references-count":7,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["10.1177\/10781552211045009"],"URL":"https:\/\/doi.org\/10.1177\/10781552211045009","relation":{},"ISSN":["1078-1552","1477-092X"],"issn-type":[{"value":"1078-1552","type":"print"},{"value":"1477-092X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,5]]}}}